References
Blue Ribbon Study Panel on Biodefense. 2015. A national blueprint for biodefense: Leadership and major reform needed to optimize efforts. Washington, DC: Blue Ribbon Study Panel on Biodefense.
IOM and NRC (Institute of Medicine and National Research Council). 2011. BioWatch and public health surveillance: Evaluating systems for the early detection of biological threats: Abbreviated version. Washington, DC: The National Academies Press.
IOM and NRC. 2014. Technologies to enable autonomous detection for BioWatch: Ensuring timely and accurate information for public health officials: Workshop summary. Washington, DC: The National Academies Press.
Kalb, S. R., A. E. Boyer, and J. R. Barr. 2015. Mass spectrometric detection of bacterial protein toxins and their enzymatic activity. Toxins 7(9):3497–3511.
Kumar, A., D. Roberts, K. E. Wood, B. Light, J. E. Parrillo, S. Sharma, R. Suppes, D. Feinstein, S. Zanotti, L. Taiberg, D. Gurka, A. Kumar, and M. Cheang. 2006. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Critical Care Medicine 34(6):1589–1596.
Lu, H., F. Giordano, and Z. Ning. 2016. Oxford nanopore minion sequencing and genome assembly. Genomics Proteomics Bioinformatics 14(5):265–279.
NASEM (National Academies of Sciences, Engineering, and Medicine). 2016. Enhancing BioWatch capabilities through technology and collaboration: Proceedings of a workshop, edited by J. Alper. Washington, DC: The National Academies Press.
Presidential Commission. 1986. Report to the president by the Presidential Commission on the Space Shuttle Challenger Accident. Washington, DC: National Aeronautics and Space Administration.
Walter, M. V. 2014. BioWatch program overview: Briefing on PCR standards. Presentation to the Committee on PCR Standards for the BioWatch Program. Washington, DC.
